| |
 |
|
This is a partial list of the projects currently
under development in our laboratory. The foundation of our work
are the methods we develop to deliver new ways to interpret and
solve biomedical problems. These methods are then used to tackle
critical research questions in many biomedical areas and, in particular,
in many aspects of genetic research, including genomics, transcriptomics,
proteomics and pharmacogenomics.
|
| |
|
methods and databases |
| |
|
|
| |
|
genomics |
| |
|
|
| |
|
transcriptomics |
| |
|
|
| |
|
proteomics |
| |
|
|
gopad:
the goal of this project is to present relevant information
theoretic statistics featuring ontology partitions with
Gene Ontology
terms of similar specificity to facilitate researchers to
analyze information at arbitrary levels.
|
|
|
|
|
biofluidome:
the aim of this project is to develop a comprehensive framework
to identify which biofuilds are most likely to carry peripheral
markers of disease or therapeutic response in specific tissues.
|
| |
|
 |
massome:
this project provides the largest non-redundant network
of human protein-protein interactions ever assembled for
information that can be used from network architecture about
its embedded proteins.
|
| |
|
 |
go
infocube: this project allows investigators to design
and analyze nascent parallelization technologies (e.g. protein
microarrays) by projecting constituent proteins/genes onto
three application-specific dimensions within Gene
Ontology.
|
| |
|
|
| |
|
phenomics |
| |
|
|
the functional
landscape of chemotherapy toxicities: the goal of this
project is to create an integrated landscape of the relationships
between toxicities induced by chemotherapy an develop a
prognostic system able to forecast the insurgence of these
toxicities.
|
|
| |
|
pharmacogenomics |
| |
|
|
multigenic
dissection of therapy response in asthmatic patients:
the goal of this project is to indentify the genetic basis
that make some asthma patients more sensitive to treatment
than others and to develop a genomic prognostic model for
such a response.
|
| |
|
|
in silico
pharmacogenomics: the goal of this project is to develop
a model of interaction among genes able to reveal the critical
point of cancer proliferation and predict the effectiveness
of anti-cancer compounds on the basis of the genes they
affect.
|
|
| |